United States· US:65145-194_fbbd8380-9848-4862-8c73-2f53fcdf7120
POTASSIUM PHOSPHATES
A medicinal product containing potassium phosphate, monobasic; potassium phosphate, dibasic, registered in United States by Caplin Steriles Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- POTASSIUM PHOSPHATE, MONOBASIC; POTASSIUM PHOSPHATE, DIBASIC
- Manufacturer
- Caplin Steriles Limited
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 13, 2026
Packs & prices · 2
- ndc11651451942525 VIAL, SINGLE-DOSE in 1 CARTON (65145-194-25) / 5 mL in 1 VIAL, SINGLE-DOSE (65145-194-01)
- ndc1165145-194-25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Potassium phosphate, monobasic; potassium phosphate, dibasic in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaPOTASSIUM PHOSPHATESSANDOZ CANADA INCORPORATED
- GermanyKaliumphosphat B. BraunB.Braun Melsungen Ag
- IrelandPotassium Phosphate 1mmol/ml + 0.6mmol/ml Concentrate for Solution for InfusionB. Braun Medical Limited
- NorwayPotassio fosfato galenica seneseIndustria Farmaceutica Galenica Senese
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Belgium · Kaliphos, Kaliumfosfaat B. Braun
- Germany · Kaliumphosphat B. Braun
- Ireland · Potassium Phosphate B Braun Medical
- Italy · Potassio Fosfato Bioindustria L.I.M., Potassio Fosfato Galenica Senese
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e79db898-77ac-4c29-a070-89b4388236c1 GET /v1/drugs/e79db898-77ac-4c29-a070-89b4388236c1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "224; 236",
"substance": "POTASSIUM PHOSPHATE, MONOBASIC; POTASSIUM PHOSPHATE, DIBASIC",
"productndc": "65145-194",
"dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL",
"application_number": "ANDA220373",
"marketing_category": "ANDA"
}See everything about potassium phosphate, monobasic; potassium phosphate, dibasic.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.